Azusa Yoneshige
Man Hagiyama
Mitsugu Fujita
Akihiko Ito- 1Department of Pathology, Faculty of Medicine, Kinki University, Osaka, Japan
- 2Department of Microbiology, Faculty of Medicine, Kinki University, Osaka, Japan
Cell adhesion mediated by adhesion molecules is of central importance in the maintenance of tissue homeostasis. Therefore, altered expression of adhesion molecules leads to the development of various tissue disorders involving cell activation, degeneration, and apoptosis. Nevertheless, it still remains unclear what initiates the altered expression of adhesion molecules and how the subsequent pathological cascades proceed. In this regard, cell adhesion molecule 1 (CADM1) is one of the candidates that is involved in the development of pathological lesions; it is an intercellular adhesion molecule that is expressed in various types of cells such as pulmonary cells, neurons, and mast cells. Recent studies have revealed that alterations in the transcriptional or post-transcriptional expressions of CADM1 correlate with the pathogenesis of pulmonary diseases and allergic diseases. In this review, we specifically focus on how CADM1 is involved in the development of pathological lesions in pulmonary emphysema and atopic dermatitis.
Function of CADM1 Under Normal Conditions
In the last two or three decades, a line of studies have revealed the molecular basis of cell adhesion to neighboring cells and surrounding extracellular matrices in our body. That is, cell adhesion is of crucial importance in human body homeostasis (Macara et al., 2014). Dedicated proteins directly mediating cell adhesion have been revealed such as cadherins, integrins, selectins, and immunoglobulin superfamily members; they are now called “adhesion molecules” (Coombe and Dye, 2010).
In particular, accumulating data demonstrate the importance of cell adhesion molecule 1 (CADM1), which is an intercellular adhesion molecule that belongs to the immunoglobulin (Ig) superfamily (Kuramochi et al., 2001). CADM1 comprises three major functional domains: an extracellular Ig-like domain, a single transmembrane region, and a short carboxy-terminal intracytoplasmic tail that is further composed of a protein 4.1-binding motif and a PDZ type II domain-binding motif (Kuramochi et al., 2001). Historically, CADM1 has had several nomenclatures such as spermatogenic immunoglobulin superfamily (SgIGSF), tumor suppressor in lung cancer 1 (TSLC1), nectin-like molecule 2 (Necl2), and synaptic cell adhesion molecule (SynCAM), based on its diverse functional nature in various cell lineages such as spermatogonia, lung epithelial cells, and neurons (Watabe et al., 2003). We have previously demonstrated that CADM1 is expressed in mast cells (Ito et al., 2003), biliary cells (Ito et al., 2007), pancreatic endocrine cells (Koma et al., 2008), and osteoblasts (Inoue et al., 2013). In addition, CADM1 has been shown to have several splicing isoforms; these isoforms expressed on the cell surface are named SP1 to SP4 based on the difference in the length of the juxtamembranous extracellular region (Biederer, 2006). Lung epithelial cells and mast cells exclusively express the SP4 isoform whereas neurons express various combinations of these four isoforms (Ito et al., 2003; Sakurai-Yageta et al., 2009; Hagiyama et al., 2011).
In epithelia, CADM1 is located on the lateral cell membrane and mediates neighboring cell adhesion via trans-homophilic interaction (Koma et al., 2008; Ito et al., 2012). CADM1 directly interacts with a spectrin-actin-binding protein DAL1 through the intracytoplasmic protein 4.1-binding motif to promote the formation of epithelial cell morphology (Yageta et al., 2002; Sakurai-Yageta et al., 2009). CADM1 also interacts with a membrane-associated guanylate kinase PALS2 through the PDZ type II domain-binding motif; this interaction controls epithelial cell polarity (Shingai et al., 2003; Wu et al., 2007). In mast cells, CADM1 mediates their adhesion to fibroblasts (Ito et al., 2003), airway smooth muscle cells (Moiseeva et al., 2013), and neurons (Furuno et al., 2005). In particular, CADM1 plays a central role in the direct cell-to-cell contact between mast cells and unmyelinated C-fibers of sensory neurons through trans-homophilical interaction to promote neurno-immune interaction between them (Furuno et al., 2005).
Pathogenic Actions of CADM1 in Pulmonary Emphysema
Pathologically, the adhesion molecules is involved in the development and progression of diseases and disorders such as tumors (Demetriou and Cress, 2004), inflammatory diseases (Macauley et al., 2014), and neurological diseases (Berezin et al., 2014). Then, how can they be pathogenic without genetic mutations? One of possible mechanisms is their susceptibility to proteolysis. Since the adhesion molecules are expressed on the cell membrane, they often undergo extra- and inter-membraneous enzymatic cleavage; this phenomenon is termed “ectodomain shedding” (Edwards et al., 2008). CADM1 is shed at the extracellular domain by a disintegrin and metalloproteinase 10 (ADAM10) protease to produce a membrane-bound α C-terminal fragment (αCTF); CADM1 is also shed by yet unidentified proteases to produce βCTF (Nagara et al., 2012; Mimae et al., 2014). Tobacco smoking is known to induce an imbalanced increase in protease activity within lung alveoli (Taraseviciene-Stewart and Voelkel, 2008). As a consequence, lung epithelial CADM1 is shed in smokers’ lungs at high levels to produce a substantial amount of αCTF and βCTF. Then, αCTF enters into the lung epithelial cytoplasm, accumulates in mitochondria, and depolarizes the mitochondrial outer membrane potential; this process results in mitochondrial apoptotic pathway (Mimae et al., 2014). Because the full-length CADM1 plays an important role in the maintenance of epithelial polarity (Sakurai-Yageta et al., 2009), an increase in CADM1 shedding with an accompanying decrease in the full-length CADM1 induces the disruption of alveolar cell polarity and the cell apoptosis (Yoneshige et al., 2015).
There is the third CADM1 shedding event; the truncated products αCTF and βCTF can be further cleaved within its transmembrane region by γ-secretase to produce free fragments of the intracellular domain (ICD; Nagara et al., 2012). In a similar fashion to αCTF, ICD moves into mitochondria and induces apoptosis of lung epithelial cells (Hagiyama et al., 2015). Through these events, CADM1 is involved in the development and progression of pulmonary emphysema, a smoking-related lung degenerative disease characterized by the peripheral airspace enlargement associated with increased apoptosis of alveolar cells (Mimae et al., 2014; Figure 1). Similarly, CADM1-mediated pathological mechanisms have been proven in idiopathic interstitial pneumonia by inducing the apoptosis of type 2 alveolar cells (Yoneshige et al., 2015) and type 2 diabetic pancreas by inducing the apoptosis of insulin-secreting islet β cells (Inoue et al., 2014).
Figure 1. Increased ectodomain shedding of CADM1 as a cause of epithelial cell apoptosis. In epithelia, CADM1 is located on the lateral cell membrane and mediates neighboring cell adhesion via trans-homophilic binding. Under pathological conditions, ectodomain shedding of CADM1 is induced through an imbalanced increase in protease activity such as neutrophil elastases, macrophage matrix metalloproteinases, and/or the inactivation of anti-protease α1-antitrypsin. CADM1 is shed at the extracellular domain by a disintegrin and metalloproteinase 10 (ADAM10) protease to produce a membrane-bound α C-terminal fragment (αCTF). Then, the truncated product αCTF enters into cytoplasm, accumulates in mitochondria, and depolarizes the mitochondrial outer membrane potential; this process results in mitochondrial apoptotic pathway. αCTF can be further cleaved within its transmembrane region by γ-secretase to produce free fragments of the intracellular domain (ICD). In similar to αCTF, ICD moves into mitochondria and induces apoptosis of lung epithelial cells. An increase in CADM1 shedding with an accompanying decrease in the full-length CADM1 induces the disruption of alveolar cell polarity and the cell apoptosis.
Pathogenic Actions of CADM1 in Atopic Dermatitis
We have also demonstrated pathological roles of CADM1 in atopic dermatitis (Hagiyama et al., 2013). It has long been known that pathological cell adhesion is observed between nerve fibers and mast cells in atopic dermatitis lesions (Jarvikallio et al., 2003). Here, mast cells are immune cells featured by cytoplasmic granules containing various bioactive molecules. Their unique characteristics is that, unlike other immune cells, they exist in the digestive and respiratory mucosa and skin dermis at a certain cell density under healthy conditions (Kitamura et al., 2007). Under pathological conditions, however, the number of mast cells is increased through the proliferation of tissue-resident mast cells and also the recruitment from circulating myeloid progenitor cells (Jung and Scholz, 2008).
In a mouse model of hapten-induced atopic dermatitis, dermal mast cells were observed in contact with nerve fibers at high frequencies (Shiohara et al., 2004). Our laser capture microdissection-based RT-qPCT analyses revealed that the lesional mast cells expressed CADM1 mRNA at approximately five-fold higher levels than those in the normal skin (Hagiyama et al., 2013). This altered CADM1 expression appears to be induced by the basic helix-loop-helix type microphthalmia-transcription factor (MITF), a key factor for mast cell differentiation (Ito et al., 2003). When neurons and mast cells are co-cultured, the kinetic strength (force-induced dissociation rate) of mast cell adhesion to nerve fibers varies dependently on the expression levels of CADM1 on mast cells (Hagiyama et al., 2013). We have previously shown that the CADM1-expressing mast cells interact with neurons to secrete substance P and that such neuron-derived substance P further interacts with the cognate receptor neurokinin that is 1 expressed on the mast cells to induce their degranulation (Furuno et al., 2004, 2005). Taken together, these data suggest that neuron-mast cell adhesion (so called “neuro-immune interaction”) might be strengthened in atopic dermatitis through an increased expression of CADM1 in mast cells. This mechanism is recently highlighted as a molecular basis that can explain why mental stress exacerbates atopic dermatitis (Figure 2).
Figure 2. CADM1-mediated nerve–mast cell interaction in the atopic dermatitis skin lesion. Dermal mast cells are observed in contact with nerve fibers in the atopic dermatitis. These lesional mast cells express CADM1 at higher levels than those in the normal skin, which is induced by the basic helix-loop-helix type microphthalmia-transcription factor (MITF). CADM1-expressing mast cells interact with neurons to secrete substance P (SP), and the neuron-derived substance P further interacts with the cognate receptor neurokinin 1 (NK-1) expressed on the mast cells to induce their degranulation.
Concluding Remarks
As reviewed here, CADM1 is involved in the development of pulmonary emphysema through its ectodomain shedding in lung epithelial cells by promoting the apoptosis of lung epithelial cells. Since apoptotic cell death is frequently observed in various degenerative diseases, future studies may identify the protease-mediated shedding of adhesion molecules as a common cause for tissue degeneration. Furthermore, an increased expression of CADM1 is involved in the development of atopic dermatitis by promoting the neuro-immune interaction. Recent advances in biological experimental techniques and future studies may identify this lesion-specific cell adhesion as a major cause of various inflammatory diseases.
Author Contributions
AY, MH, and MF helped to draft the manuscript, AI conceived of this review article and drafted the manuscript.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
The authors thank Ms. Heather A. McDonald (Three Rivers Research Partners) for her extensive proofreading of the manuscript. This study was supported by the Japan Society for the Promotion of Science KAKENHI (26860267 to AY, 25860302 to MH, and 24590492 to AI).
References
Berezin, V., Walmod, P. S., Filippov, M., and Dityatev, A. (2014). Targeting of ECM molecules and their metabolizing enzymes and receptors for the treatment of CNS diseases. Prog. Brain Res. 214, 353–388. doi: 10.1016/B978-0-444-63486-3.00015-3
Biederer, T. (2006). Bioinformatic characterization of the SynCAM family of immunoglobulin-like domain-containing adhesion molecules. Genomics 87, 139–150. doi: 10.1016/j.ygeno.2005.08.017
Coombe, D. R., and Dye, D. E. (2010). “Feature, structure, and classification of adhesion molecules: an overview,” in Adhesion Molecules, ed V. R. Preedy (Boca Raton, FL: CRC Press), 1–20. doi: 10.1201/b10167-2
Demetriou, M. C., and Cress, A. E. (2004). Integrin clipping: a novel adhesion switch? J. Cell. Biochem. 91, 26–35. doi: 10.1002/jcb.10675
Edwards, D. R., Handsley, M. M., and Pennington, C. J. (2008). The ADAM metalloproteinases. Mol. Aspects Med. 29, 258–289. doi: 10.1016/j.mam.2008.08.001
Furuno, T., Ito, A., Koma, Y., Watabe, K., Yokozaki, H., Bienenstock, J., et al. (2005). The spermatogenic Ig superfamily/synaptic cell adhesion molecule mast-cell adhesion molecule promotes interaction with nerves. J. Immunol. 174, 6934–6942. doi: 10.4049/jimmunol.174.11.6934
Furuno, T., Ma, D., van der Kleij, H. P., Nakanishi, M., and Bienenstock, J. (2004). Bone marrow-derived mast cells in mice respond in co-culture to scorpion venom activation of superior cervical ganglion neurites according to level of expression of NK-1 receptors. Neurosci. Lett. 372, 185–189. doi: 10.1016/j.neulet.2004.08.008
Hagiyama, M., Furuno, T., Hosokawa, Y., Iino, T., Ito, T., Inoue, T., et al. (2011). Enhanced nerve-mast cell interaction by a neuronal short isoform of cell adhesion molecule-1. J. Immunol. 186, 5983–5992. doi: 10.4049/jimmunol.1002244
Hagiyama, M., Inoue, T., Furuno, T., Iino, T., Itami, S., Nakanishi, M., et al. (2013). Increased expression of cell adhesion molecule 1 by mast cells as a cause of enhanced nerve-mast cell interaction in a hapten-induced mouse model of atopic dermatitis. Br. J. Dermatol. 168, 771–778. doi: 10.1111/bjd.12108
Hagiyama, M., Yoneshige, A., Inoue, T., Sato, Y., Mimae, T., Okada, M., et al. (2015). The intracellular domain of cell adhesion molecule 1 is present in emphysematous lungs and induces lung epithelial cell apoptosis. J. Biomed. Sci. 22, 67. doi: 10.1186/s12929-015-0173-8
Inoue, T., Hagiyama, M., Enoki, E., Sakurai, M. A., Tan, A., Wakayama, T., et al. (2013). Cell adhesion molecule 1 is a new osteoblastic cell adhesion molecule and a diagnostic marker for osteosarcoma. Life Sci. 92, 91–99. doi: 10.1016/j.lfs.2012.10.021
Inoue, T., Hagiyama, M., Yoneshige, A., Kato, T., Enoki, E., Maenishi, O., et al. (2014). Increased ectodomain shedding of cell adhesion molecule 1 from pancreatic islets in type 2 diabetic pancreata: correlation with hemoglobin A1c levels. PLoS ONE 9:e100988. doi: 10.1371/journal.pone.0100988
Ito, A., Ichiyanagi, N., Ikeda, Y., Hagiyama, M., Inoue, T., Kimura, K. B., et al. (2012). Adhesion molecule CADM1 contributes to gap junctional communication among pancreatic islet α-cells and prevents their excessive secretion of glucagon. Islets 4, 49–55. doi: 10.4161/isl.18675
Ito, A., Jippo, T., Wakayama, T., Morii, E., Koma, Y., Onda, H., et al. (2003). SgIGSF: a new mast-cell adhesion molecule used for attachment to fibroblasts and transcriptionally regulated by MITF. Blood 101, 2601–2608. doi: 10.1182/blood-2002-07-2265
Ito, A., Nishikawa, Y., Ohnuma, K., Ohnuma, I., Koma, Y., Sato, A., et al. (2007). SgIGSF is a novel biliary-epithelial cell adhesion molecule mediating duct/ductule development. Hepatology 45, 684–694. doi: 10.1002/hep.21501
Jarvikallio, A., Harvima, I. T., and Naukkarinen, A. (2003). Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 295, 2–7. doi: 10.1007/s00403-002-0378-z
Jung, J. F., and Scholz, L. T. (2008). Mast Cells: Roles, Interactions, and Disorders. New York, NY: Nova Biomedical Books.
Kitamura, Y., Oboki, K., and Ito, A. (2007). Development of mast cells. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 83, 164–174. doi: 10.2183/pjab.83.164
Koma, Y., Furuno, T., Hagiyama, M., Hamaguchi, K., Nakanishi, M., Masuda, M., et al. (2008). Cell adhesion molecule 1 is a novel pancreatic-islet cell adhesion molecule that mediates nerve-islet cell interactions. Gastroenterology 134, 1544–1554. doi: 10.1053/j.gastro.2008.01.081
Kuramochi, M., Fukuhara, H., Nobukuni, T., Kanbe, T., Maruyama, T., Ghosh, H. P., et al. (2001). TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat. Genet. 27, 427–430. doi: 10.1038/86934
Macara, I. G., Guyer, R., Richardson, G., Huo, Y., and Ahmed, S. M. (2014). Epithelial homeostasis. Curr. Biol. 24, R815–R825. doi: 10.1016/j.cub.2014.06.068
Macauley, M. S., Crocker, P. R., and Paulson, J. C. (2014). Siglec-mediated regulation of immune cell function in disease. Nat. Rev. Immunol. 14, 653–666. doi: 10.1038/nri3737
Mimae, T., Hagiyama, M., Inoue, T., Yoneshige, A., Kato, T., Okada, M., et al. (2014). Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysema. Thorax 69, 223–231. doi: 10.1136/thoraxjnl-2013-203867
Moiseeva, E. P., Roach, K. M., Leyland, M. L., and Bradding, P. (2013). CADM1 is a key receptor mediating human mast cell adhesion to human lung fibroblasts and airway smooth muscle cells. PLoS ONE 8:e61579. doi: 10.1371/journal.pone.0061579
Nagara, Y., Hagiyama, M., Hatano, N., Futai, E., Suo, S., Takaoka, Y., et al. (2012). Tumor suppressor cell adhesion molecule 1 (CADM1) is cleaved by a disintegrin and metalloprotease 10 (ADAM10) and subsequently cleaved by gamma-secretase complex. Biochem. Biophys. Res. Commun. 417, 462–467. doi: 10.1016/j.bbrc.2011.11.140
Sakurai-Yageta, M., Masuda, M., Tsuboi, Y., Ito, A., and Murakami, Y. (2009). Tumor suppressor CADM1 is involved in epithelial cell structure. Biochem. Biophys. Res. Commun. 390, 977–982. doi: 10.1016/j.bbrc.2009.10.088
Shingai, T., Ikeda, W., Kakunaga, S., Morimoto, K., Takekuni, K., Itoh, S., et al. (2003). Implications of nectin-like molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cell-cell adhesion and transmembrane protein localization in epithelial cells. J. Biol. Chem. 278, 35421–35427. doi: 10.1074/jbc.M305387200
Shiohara, T., Hayakawa, J., and Mizukawa, Y. (2004). Animal models for atopic dermatitis: are they relevant to human disease? J. Dermatol. Sci. 36, 1–9. doi: 10.1016/j.jdermsci.2004.02.013
Taraseviciene-Stewart, L., and Voelkel, N. F. (2008). Molecular pathogenesis of emphysema. J. Clin. Invest. 118, 394–402. doi: 10.1172/JCI31811
Watabe, K., Ito, A., Koma, Y. I., and Kitamura, Y. (2003). IGSF4: a new intercellular adhesion molecule that is called by three names, TSLC1, SgIGSF and SynCAM, by virtue of its diverse function. Histol. Histopathol. 18, 1321–1329.
Wu, V. M., Yu, M. H., Paik, R., Banerjee, S., Liang, Z., Paul, S. M., et al. (2007). Drosophila Varicose, a member of a new subgroup of basolateral MAGUKs, is required for septate junctions and tracheal morphogenesis. Development 134, 999–1009. doi: 10.1242/dev.02785
Yageta, M., Kuramochi, M., Masuda, M., Fukami, T., Fukuhara, H., Maruyama, T., et al. (2002). Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer. Cancer Res. 62, 5129–5133.
Yoneshige, A., Hagiyama, M., Inoue, T., Mimae, T., Kato, T., Okada, M., et al. (2015). Increased ectodomain shedding of cell adhesion molecule 1 as a cause of type II alveolar epithelial cell apoptosis in patients with idiopathic interstitial pneumonia. Respir. Res. 16:90. doi: 10.1186/s12931-015-0255-x
Keywords: degeneration, apoptosis, protease imbalance, ectodomain shedding, neuro-immune interaction
Citation: Yoneshige A, Hagiyama M, Fujita M and Ito A (2015) Pathogenic Actions of Cell Adhesion Molecule 1 in Pulmonary Emphysema and Atopic Dermatitis. Front. Cell Dev. Biol. 3:75. doi: 10.3389/fcell.2015.00075
Received: 10 September 2015; Accepted: 09 November 2015;
Published: 20 November 2015.
Edited by:
Vladimir Sytnyk, University of New South Wales, AustraliaReviewed by:
Igor Jakovcevski, German Center for Neurodegenerative Diseases, GermanyIryna Leshchyns’Ka, University of New South Wales, Australia
Copyright © 2015 Yoneshige, Hagiyama, Fujita and Ito. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Akihiko Ito, aito@med.kindai.ac.jp